Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on April 1, 2025
Combatting Cyber Threats with AI: Darktrace and Climb Channel Solutions Sign Distribution Agreement for North America
GlobeNewswire
·
April 1, 2025
EATONTOWN, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) today announced a new partnership with Darktrace, a …
Rio Silver Pivots to High-Grade Silver Exploration / Exploitation - Announces Executive Changes
GlobeNewswire
·
April 1, 2025
VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that it has appointed Eric H. Hinton, P.Eng., FCIM, to the Advisory Board. Eric H. Hinton, P.Eng., FCIM, has …
CECO Environmental Announces Completion of the Divestiture of Its Fluid Handling Business to May River Capital
GlobeNewswire
·
April 1, 2025
ADDISON, Texas, April 01, 2025 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced it has …
Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation
GlobeNewswire
·
April 1, 2025
New REVEAL-1 study results show early signs of weight maintenance after GLP-1 discontinuation REMAIN-1 pivotal study now more than 50% enrolled; midpoint data analysis anticipated in Q3 2025 BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Fractyl …
Itafos Confirms Declaration of Special Dividend
GlobeNewswire
·
April 1, 2025
HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (the “Company”) confirms its previously announced declaration of a CAD$0.05 per share special cash dividend approved by its Board of Directors on March 19, 2025, payable on April 25, …
INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study
GlobeNewswire
·
April 1, 2025
MINDFuL Phase II Blinded, Randomized, Placebo-Controlled Data Anticipated June 2025 Boca Raton, Florida, April 01, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on …
Tovecimig (CTX-009) Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
GlobeNewswire
·
April 1, 2025
Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel achieved a 17.1% overall response rate (ORR), including one complete response, compared to 5.3% ORR for paclitaxel alone, in patients with biliary tract cancer (BTC) treated in …
3D Systems Completes Sale of Geomagic Software Portfolio
GlobeNewswire
·
April 1, 2025
Closed transaction for $123 million, with expected net proceeds of approximately $100 million to strengthen balance sheet and invest in future growth and profitability initiatives Sharpens focus on core additive manufacturing software solutions — 3D Sprint …
Medicenna to Present at Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 1, 2025
TORONTO and HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …
Cielo Announces Relocation of First Planned Facility to British Columbia and Provides Update on Proposed Asset Acquisition and Corporate Matters
GlobeNewswire
·
April 1, 2025
CALGARY, Alberta, April 01, 2025 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV:CMC; OTC PINK:CWSFF) (“Cielo” or the “Company”) provides an update on certain business and corporate matters. First Planned Waste to Fuels Facility – Scrap Railway Ties …
Codexis Appoints Cynthia Collins to Board of Directors
GlobeNewswire
·
April 1, 2025
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Cynthia Collins to the Company’s …
Parc éolien de Limekiln, Écosse : Un premier site de production en opération pour Boralex au Royaume-Uni
GlobeNewswire
·
April 1, 2025
ÉDIMBOURG, Royaume-Uni, 01 avr. 2025 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) est heureuse d’annoncer que toutes les turbines du parc éolien de Limekiln sont opérationnelles. Le parc éolien de Limekiln, situé près de …
Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film
GlobeNewswire
·
April 1, 2025
Reports positive pharmacokinetic (PK) results from the recently completed pediatric study for Anaphylm™ Completes submission of its New Drug Application (NDA) for Anaphylm to the FDA; NDA acceptance expected in Q2 2025 WARREN, N.J., April 01, 2025 (GLOBE …
Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (MDD) with and without Excessive Daytime Sleepiness (EDS)
GlobeNewswire
·
April 1, 2025
Results support continued development in MDD with concomitant EDS; Phase 3 trial planned in 2025 Approximately 50 percent of MDD patients experience EDS1, highlighting high unmet need NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. ( …
Limekiln Wind Farm, Scotland: Boralex’s First Production Site in the United Kingdom Now Operational
GlobeNewswire
·
April 1, 2025
EDINBURGH, United Kingdom, April 01, 2025 (GLOBE NEWSWIRE) -- Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) is pleased to announce that the Limekiln Wind Farm and all its turbines are operational. Limekiln Wind Farm, located near Thurso in Caithness …
AmpliTech Reports FY 2024 Financial Results
GlobeNewswire
·
April 1, 2025
HAUPPAUGE, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG), a leading designer, developer, and manufacturer of advanced signal-processing components for satellite, 5G, and other communication networks, including complete 5G/6G …
Trust Stamp files its 2024 10-K and gives forward-looking revenue and expense guidance
GlobeNewswire
·
April 1, 2025
Atlanta, GA, April 01, 2025 (GLOBE NEWSWIRE) -- Trust Stamp announces that: It filed its 10-K report for the 2024 Financial Year after the Nasdaq market closed on March 31st, 2025. Q4 2024 Revenue was $1.50m increased from $0.51m for Q3 of 2024 and $0.58m …
Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest
GlobeNewswire
·
April 1, 2025
Wilmington, Del., April 01, 2025 (GLOBE NEWSWIRE) -- Ashland has completed a 10-million-dollar expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil and will celebrate the occasion with a ribbon-cutting ceremony on April 4, 2025. The …
Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission
GlobeNewswire
·
April 1, 2025
ZUG, Switzerland, April 01, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases …
Sysmex’s PA-100 AST System: Revolutionising UTI diagnosis and treatment with precision
GlobeNewswire
·
April 1, 2025
PARIS, April 01, 2025 (GLOBE NEWSWIRE) -- Sysmex’s PA-100 AST System is redefining standard of care for diagnosing and treating urinary tract infections (UTIs). By combining cutting-edge nanofluidic technology with rapid antimicrobial susceptibility …